ZTS Q3 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+9.9% YoY

Gross Profit

$975M65.9% margin

Operating Income

$529M35.7% margin

Net Income

$347M23.4% margin

EPS (Diluted)

$0.71

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$550M

Free Cash Flow

$476M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$10.5B

Total Liabilities

$8.3B

Stockholders' Equity

$2.1B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.3B	+9.9%
Gross Profit	$975M	$889M	+9.7%
Operating Income	$529M	$465M	+13.8%
Net Income	$347M	$298M	+16.4%

Revenue Segments

Dogs and Cats

$653M45%

Cattle

$417M29%

Swine

$160M11%

Poultry

$130M9%

Fish

$46M3%

Horses

$35M2%

Geographic Segments

UNITED STATES

$757M73%

BRAZIL

$72M7%

CHINA

$46M4%

CANADA

$42M4%

GERMANY

$36M3%

FRANCE

$29M3%

SPAIN

$28M3%

ITALY

$27M3%